TY - JOUR
T1 - Effects of Rapid Uptitration of Neurohormonal Blockade on Effective, Sustainable Decongestion and Outcomes in STRONG-HF
AU - Biegus, Jan
AU - Mebazaa, Alexandre
AU - Davison, Beth
AU - Cotter, Gad
AU - Edwards, Christopher
AU - Čelutkienė, Jelena
AU - Chioncel, Ovidiu
AU - Cohen-Solal, Alain
AU - Filippatos, Gerasimos
AU - Novosadova, Maria
AU - Sliwa, Karen
AU - Adamo, Marianna
AU - Arrigo, Mattia
AU - Lam, Carolyn S.P.
AU - Ter Maaten, Jozine M.
AU - Deniau, Benjamin
AU - Barros, Marianela
AU - Čerlinskaitė-Bajorė, Kamilė
AU - Damasceno, Albertino
AU - Diaz, Rafael
AU - Gayat, Etienne
AU - Kimmoun, Antoine
AU - Pang, Peter S.
AU - Pagnesi, Matteo
AU - Saidu, Hadiza
AU - Takagi, Koji
AU - Tomasoni, Daniela
AU - Voors, Adriaan A.
AU - Metra, Marco
AU - Ponikowski, Piotr
N1 - Publisher Copyright:
© 2024 American College of Cardiology Foundation
PY - 2024/7/23
Y1 - 2024/7/23
N2 - Background: Comprehensive uptitration of neurohormonal blockade targets fundamental mechanisms underlying development of congestion and may be an additional approach for decongestion after acute heart failure (AHF). Objectives: This hypothesis was tested in the STRONG-HF (Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of Heart Failure Therapies) trial. Methods: In STRONG-HF, patients with AHF were randomized to the high-intensity care (HIC) arm with fast up-titration of neurohormonal blockade or to usual care (UC). Successful decongestion was defined as an absence of peripheral edema, pulmonary rales, and jugular venous pressure <6 cm. Results: At baseline, the same proportion of patients in both arms had successful decongestion (HIC 48% vs UC 46%; P = 0.52). At day 90, higher proportion of patients in the HIC arm (75%) experienced successful decongestion vs the UC arm (68%) (P = 0.0001). Each separate component of the congestion score was significantly better in the HIC arm (all, P < 0.05). Additional markers of decongestion also favored the HIC: weight reduction (adjusted mean difference: −1.36 kg; 95% CI: −1.92 to −0.79 kg), N-terminal pro–B-type natriuretic peptide level, and lower orthopnea severity (all, P < 0.001). More effective decongestion was achieved despite a lower mean daily dose of loop diuretics at day 90 in the HIC arm. Among patients with successful decongestion at baseline, those in the HIC arm had a significantly better chance of sustaining decongestion at day 90. Successful decongestion in all subjects was associated with a lower risk of 180-day HF readmission or all-cause death (HR: 0.40; 95% CI: 0.27-0.59; P < 0.0001). Conclusions: In STRONG-HF, intensive uptitration of neurohormonal blockade was associated with more efficient and sustained decongestion at day 90 and a lower risk of the primary endpoint.
AB - Background: Comprehensive uptitration of neurohormonal blockade targets fundamental mechanisms underlying development of congestion and may be an additional approach for decongestion after acute heart failure (AHF). Objectives: This hypothesis was tested in the STRONG-HF (Safety, Tolerability, and Efficacy of Rapid Optimization, Helped by N-Terminal Pro–Brain Natriuretic Peptide Testing of Heart Failure Therapies) trial. Methods: In STRONG-HF, patients with AHF were randomized to the high-intensity care (HIC) arm with fast up-titration of neurohormonal blockade or to usual care (UC). Successful decongestion was defined as an absence of peripheral edema, pulmonary rales, and jugular venous pressure <6 cm. Results: At baseline, the same proportion of patients in both arms had successful decongestion (HIC 48% vs UC 46%; P = 0.52). At day 90, higher proportion of patients in the HIC arm (75%) experienced successful decongestion vs the UC arm (68%) (P = 0.0001). Each separate component of the congestion score was significantly better in the HIC arm (all, P < 0.05). Additional markers of decongestion also favored the HIC: weight reduction (adjusted mean difference: −1.36 kg; 95% CI: −1.92 to −0.79 kg), N-terminal pro–B-type natriuretic peptide level, and lower orthopnea severity (all, P < 0.001). More effective decongestion was achieved despite a lower mean daily dose of loop diuretics at day 90 in the HIC arm. Among patients with successful decongestion at baseline, those in the HIC arm had a significantly better chance of sustaining decongestion at day 90. Successful decongestion in all subjects was associated with a lower risk of 180-day HF readmission or all-cause death (HR: 0.40; 95% CI: 0.27-0.59; P < 0.0001). Conclusions: In STRONG-HF, intensive uptitration of neurohormonal blockade was associated with more efficient and sustained decongestion at day 90 and a lower risk of the primary endpoint.
KW - congestion
KW - decongestion
KW - GDMT
KW - neurohormonal blockade
KW - outcomes
UR - http://www.scopus.com/inward/record.url?scp=85197572715&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2024.04.055
DO - 10.1016/j.jacc.2024.04.055
M3 - Article
C2 - 39019527
AN - SCOPUS:85197572715
SN - 0735-1097
VL - 84
SP - 323
EP - 336
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 4
ER -